| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |